Related Experiment Video
Updated: Dec 13, 2025
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
Patrick M Honore1, Sebastien Redant2, Thomas Datzmann3
1ICU Department, Brugmann University Hospital, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein, 4, 1020, Brussels, Belgium. patrick.honore@chu-brugmann.be.
Background:
3,4-Methylenedioxymethamphetamine intoxication can result in potentially lethal multi-organ failure, for which the current treatment is largely supportive. Recently, a report of the use of the CytoSorb device as a part of the successful treatment of a patient with 3,4-methylenedioxymethamphetamine intoxication and multi-organ failure has been described.
Main Body:
While 3,4-methylenedioxymethamphetamine was very effectively removed by CytoSorb in vitro, the degree of removal in the clinical setting described may have been minimal. Indeed, the therapy was started relatively late in this case, and, as the therapy is concentration dependent, the removal of 3,4-methylenedioxymethamphetamine is likely to have been limited. On the other hand, in this case, CytoSorb hemoadsorption was very effective to treat rhabdomyolysis and hyperinflammation.
Conclusion:
The in vitro experimentation demonstrates that 3,4-methylenedioxymethamphetamine is effectively removed by CytoSorb. However, it is debatable whether the case report confirms the possibility of in vivo removal of 3,4-methylenedioxymethamphetamine by CytoSorb. Nevertheless, the potential of the CytoSorb device to contribute to the treatment of many critically ill patients has yet to be fully explored, and further studies are warranted.
Insights
CytoSorb effectively removes 3,4-methylenedioxymethamphetamine (MDMA) in vitro, though in-vivo removal in a clinical case was limited. The device showed efficacy in treating rhabdomyolysis and hyperinflammation during MDMA intoxication.
Area of Science:
- Critical Care Medicine
- Toxicology
- Medical Device Technology
Background:
- 3,4-Methylenedioxymethamphetamine (MDMA) intoxication can lead to life-threatening multi-organ failure, with current treatments being primarily supportive.
- A recent case report highlighted the use of the CytoSorb device in managing a patient with severe MDMA intoxication and multi-organ failure.
Discussion:
- While CytoSorb demonstrated high in vitro efficacy for MDMA removal, its clinical effectiveness in the reported case may have been minimal due to late initiation of therapy.
- The CytoSorb hemoadsorption therapy was notably effective in managing rhabdomyolysis and hyperinflammation in this patient.
Key Insights:
- In vitro studies confirm CytoSorb's capacity to efficiently remove MDMA.
- Clinical evidence for in vivo MDMA removal by CytoSorb remains inconclusive, warranting further investigation.
Outlook:
- The CytoSorb device shows potential for treating critically ill patients with various conditions.
- Further research is essential to fully explore and validate the therapeutic applications of CytoSorb in critical care settings.
More Related Videos
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
01:28Antimicrobial Effectiveness
01:16Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
01:17In Vitro Drug Dissolution: Alternative Methods